[go: up one dir, main page]

AU2002348947A1 - Compositions and methods for amplification of human stem cells - Google Patents

Compositions and methods for amplification of human stem cells

Info

Publication number
AU2002348947A1
AU2002348947A1 AU2002348947A AU2002348947A AU2002348947A1 AU 2002348947 A1 AU2002348947 A1 AU 2002348947A1 AU 2002348947 A AU2002348947 A AU 2002348947A AU 2002348947 A AU2002348947 A AU 2002348947A AU 2002348947 A1 AU2002348947 A1 AU 2002348947A1
Authority
AU
Australia
Prior art keywords
amplification
compositions
methods
stem cells
human stem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002348947A
Inventor
Sophie Amsellem-Bosq
Serge Fichelson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Publication of AU2002348947A1 publication Critical patent/AU2002348947A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1394—Bone marrow stromal cells; whole marrow

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2002348947A 2002-09-26 2002-09-26 Compositions and methods for amplification of human stem cells Abandoned AU2002348947A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2002/004319 WO2004029231A1 (en) 2002-09-26 2002-09-26 Compositions and methods for amplification of human stem cells

Publications (1)

Publication Number Publication Date
AU2002348947A1 true AU2002348947A1 (en) 2004-04-19

Family

ID=32040223

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002348947A Abandoned AU2002348947A1 (en) 2002-09-26 2002-09-26 Compositions and methods for amplification of human stem cells

Country Status (2)

Country Link
AU (1) AU2002348947A1 (en)
WO (1) WO2004029231A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101016540B (en) * 2006-02-10 2010-04-07 台湾尖端先进生技医药股份有限公司 Method for producing HOXB4 recombinant protein having histidine tag at C-terminal and use thereof
EP3712258B1 (en) 2006-04-14 2025-01-01 Astellas Institute for Regenerative Medicine Hemangio-colony forming cells
CN112280739A (en) 2008-05-06 2021-01-29 安斯泰来再生医药协会 Methods for preparing enucleated erythroid cells derived from pluripotent stem cells
EP3441462A1 (en) 2008-05-06 2019-02-13 Astellas Institute for Regenerative Medicine Hemangio colony forming cells and non-engrafting hemangio cells
WO2012048298A2 (en) 2010-10-08 2012-04-12 Caridianbct, Inc. Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions
US8961956B2 (en) 2011-11-30 2015-02-24 Ocata Therapeutics, Inc. Mesenchymal stromal cells and uses related thereto
KR102108245B1 (en) 2011-11-30 2020-05-08 아스텔라스 인스티튜트 포 리제너러티브 메디슨 Mesenchymal stromal cells and uses related thereto
CN104471059B (en) 2012-07-12 2018-04-17 珠海横琴爱姆斯坦生物科技有限公司 Mesenchymal-like stem cells derived from human embryonic stem cells, methods and applications thereof
EP3973967A1 (en) 2012-12-21 2022-03-30 Astellas Institute for Regenerative Medicine Methods for production of platelets from pluripotent stem cells and compositions thereof
WO2015073918A1 (en) 2013-11-16 2015-05-21 Terumo Bct, Inc. Expanding cells in a bioreactor
US11008547B2 (en) 2014-03-25 2021-05-18 Terumo Bct, Inc. Passive replacement of media
WO2016049421A1 (en) 2014-09-26 2016-03-31 Terumo Bct, Inc. Scheduled feed
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
US11965175B2 (en) 2016-05-25 2024-04-23 Terumo Bct, Inc. Cell expansion
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
US11629332B2 (en) 2017-03-31 2023-04-18 Terumo Bct, Inc. Cell expansion
US12234441B2 (en) 2017-03-31 2025-02-25 Terumo Bct, Inc. Cell expansion
GB2619893A (en) 2021-03-23 2023-12-20 Terumo Bct Inc Cell capture and expansion
US12209689B2 (en) 2022-02-28 2025-01-28 Terumo Kabushiki Kaisha Multiple-tube pinch valve assembly
USD1099116S1 (en) 2022-09-01 2025-10-21 Terumo Bct, Inc. Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837507A (en) * 1995-11-13 1998-11-17 The Regents Of The University Of California Hox-induced enhancement of in vivo and in vitro proliferative capacity and gene therapeutic methods

Also Published As

Publication number Publication date
WO2004029231A1 (en) 2004-04-08

Similar Documents

Publication Publication Date Title
AU2002348947A1 (en) Compositions and methods for amplification of human stem cells
AU2002319780A1 (en) Alternative compositions and methods for the culture of stem cells
AU2003259735A1 (en) Small-mer compositions and methods of use
AU2003242976A1 (en) Methods of implanting mesenchymal stem cells for tissue repair and formation
AU2003285172A1 (en) Human embryonic stem cell cultures, and compositions and methods for growing same
AU2003239159A1 (en) Placental derived stem cells and uses thereof
AU2003257937A1 (en) Methods and compositions for treatment of dermal conditions
AU2003273542A1 (en) Methods of identifying and isolating stem cells and cancer stem cells
AU2003243531A1 (en) Fermentation methods and compositions
AU2003275311A1 (en) Solid micro-perforators and methods of use
AU2003257013A1 (en) Methods and compositions for amplification of dna
AU2003286612A1 (en) Satiation implants and methods of use
AU2003276014A1 (en) Bone growth compositions and methods
EP1581169A4 (en) Compositions and methods for the treatment of natural killer cell related diseases
AU2002319054A1 (en) Multipotent stem cells from peripheral tissues and uses thereof
AU2003237987A1 (en) Novel sweetener compositions and methods of use
AU2003241313A1 (en) Compositions and methods for stem cell delivery
AU2003280458A1 (en) ss TITANIUM COMPOSITIONS AND METHODS OF MANUFACTURE THEREOF
AU2003299441A1 (en) Nf-hev compositions and methods of use
GB2414480B (en) Directed genetic modifications of human stem cells
EP1554373A4 (en) Human foreskin cells suitable for culturing stem cells
AU2003243178A1 (en) Compositions and methods for sublingual formulations of dihydroergotamine for the treatment of migraine
AU2003296469A1 (en) Dental compositions including enzymes and methods
AU2003280687A1 (en) Composition for culturing multipotent stem cells and utilization of the same
AU2003216840A1 (en) Transdifferentiation of cells and tissues

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase